Cumberland Pharmaceuticals (CPIX) Profit After Tax (2016 - 2026)
Cumberland Pharmaceuticals' Profit After Tax history spans 16 years, with the latest figure at -$1.4 million for Q4 2025.
- On a quarterly basis, Profit After Tax rose 25.76% to -$1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.8 million, a 55.83% increase, with the full-year FY2025 number at -$2.8 million, up 55.99% from a year prior.
- Profit After Tax hit -$1.4 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$1.9 million in the prior quarter.
- Over the last five years, Profit After Tax for CPIX hit a ceiling of $1.3 million in Q1 2025 and a floor of -$6.3 million in Q4 2023.
- Historically, Profit After Tax has averaged -$1.2 million across 5 years, with a median of -$1.2 million in 2022.
- Biggest five-year swings in Profit After Tax: surged 233.79% in 2021 and later crashed 1089.92% in 2024.
- Tracing CPIX's Profit After Tax over 5 years: stood at -$3.8 million in 2021, then skyrocketed by 36.07% to -$2.5 million in 2022, then plummeted by 156.21% to -$6.3 million in 2023, then surged by 69.82% to -$1.9 million in 2024, then increased by 25.76% to -$1.4 million in 2025.
- Business Quant data shows Profit After Tax for CPIX at -$1.4 million in Q4 2025, -$1.9 million in Q3 2025, and -$735207.0 in Q2 2025.